W. Sukeepaisarncharoen

Genotypic resistance profiles in antiretroviral-naive HIV-1 infections before and after initiation of first-line HAART: impact of polymorphism on resistance to therapy

Chonlaphat Sukasem, Vina Churdboonchart, W. Sukeepaisarncharoen et al. · International Journal of Antimicrobial Agents · 2008 · 33 citations

Life Sciences, Infectious Diseases, Microbiology +16

A Double-Blind, Adjuvant-Controlled Trial of Human Immunodeficiency Virus Type 1 (HIV-1) Immunogen (Remune) Monotherapy in Asymptomatic, HIV-1-Infected Thai Subjects with CD4-Cell Counts of >300

Vina Churdboonchart, Chuanchom Sakondhavat, S. Kulpradist et al. · Clinical and Diagnostic Laboratory Immunology · 2000 · 21 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

Delayed progression to AIDS in volunteers treated with long‐term HIV‐1 Immunogen (REMUNE®) therapy in Thailand

Wasun Chantratita, W. Sukeepaisarncharoen, Verapol Chandeying et al. · HIV Medicine · 2004 · 16 citations · Full text

Life Sciences, Immunology, Pharmacology +16

Comparison of amphotericin B, flucytosine and itraconazole with amphotericin B and flucytosine in the treatment of cryptococcal meningitis in AIDS.

Verajit Chotmongkol, W. Sukeepaisarncharoen, Yupa Thavornpitak · PubMed · 1997 · 15 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +15